P1203: EFFICACY AND SAFETY OF AXICABTAGENE CILOLEUCEL (AXI-CEL) FOR THE TREATMENT OF RELAPSE/REFRACTORY NON-HODGKIN LYMPHOMA: FIRST REAL-WORLD DATA IN CHINESE POPULATION

• LI Wang,
• Yuhua LI,
• Dehui Zou,
• Xiaojian Zhu,
• Dongmei Ji,
• Wenbin Qian,
• Ying Lu,
• Chunyan Ji,
• Keshu Zhou,
• Hongmei Jing,
• Hua Yang,
• Lanfang LI,
• Fei LI,
• Kailin Xu,
• Ting Niu,
• Depei Wu,
• Yu Hu,
• Wei-LI Zhao

Affiliations

LI Wang

1 Shanghai Jiao Tong University School of Medicine, Affiliated Ruijin Hospital, 200025 Shanghai, China

Yuhua LI

2 Department of Hematology, Zhujiang Hospital, Southern Medical University, 510282 Guangzhou, China

Dehui Zou

3 State Key Laboratory of Experimental Hematology, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, 300020 Tianjin, China.

Xiaojian Zhu

4 Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, 430022 Wuhan, China

Dongmei Ji

5 Department of Medical Oncology, Fudan University Shanghai Cancer Center, 200032 Shanghai, China

Wenbin Qian

6 Department of Hematology, The Second Affiliated Hospital, College of Medicine, Zhejiang University, 310003 Hangzhou, China

Ying Lu

7 Department of Hematology, Yinzhou Hospital, Affiliated to College of Medicine, Ningbo University, 315201 Ningbo, China

Chunyan Ji

8 Department of Hematology, Qilu Hospital Cheeloo College of Medicine, Shandong University, 250063 Jinan, China

Keshu Zhou

9 Department of Hematology, Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, 50003 Zhengzhou, China

Hongmei Jing

10 Department of Hematology and Lymphoma Research Center, Peking University Third Hospital, 100191 Beijing, China

Hua Yang

11 Department of Hematology, Hongkong University-Shenzhen Hospital, 518040 Shenzhen, China

Lanfang LI

12 Department of Lymphoma, Tianjin Medical University Cancer Institute and Hospital, 300181 Tianjin, China

Fei LI

13 Department of Hematology, The First Affiliated Hospital of Nanchang University, 330006 Nanchang, China

Kailin Xu

14 Department of Hematology, The Affiliated Hospital of Xuzhou Medical University, 221004 Xuzhou, China

Ting Niu

15 Department of Hematology, West China Hospital, 610044 Chengdu, China

Depei Wu

16 Institute of Hematology, The First Affiliated Hospital of Soochow University, 215006 Suzhou, China

Yu Hu

17 Department of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, 430022 Wuhan, China

Wei-LI Zhao

18 Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China